Gene · 3488
Papers3,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single cells and spatial RNA profiling reveal that inflammatory fibroblasts arise from Edil3 stromal cells in the colon after irradiation. | Cell Death Differ | 2026 | 42265413 | PubTator, text mining | PubMed |
| Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via Serping1 in Cardiac Fibroblasts. | Int J Mol Sci | 2026 | 42196592 | PubTator, text mining | PubMed |
| Cycloleucine disturbs functions of porcine Sertoli cell line via modulating gene expression and metabolism. | Theriogenology | 2026 | 42119284 | PubTator, text mining | PubMed |
| A blood-brain barrier-like vascular gate limits immunotherapy efficacy in neuroendocrine cancers. | Cell | 2026 | 42102817 | PubTator, text mining | PubMed |
| A systematic review on the impact of type 2 diabetes on Leydig and Sertoli cells: Molecular mechanisms and functional consequences. | Diabetes Metab Syndr | 2026 | 42097114 | PubTator, text mining | PubMed |
| In Vitro Single-Cell Transcriptomic Profiling of Cultured Stem Cells From Apical Papilla and Dental Pulp Stem Cells: Unveiling Cellular Heterogeneity. | Int Dent J | 2026 | 42090950 | PubTator, text mining | PubMed |
| Unravelling the effects of selective estrogen receptor modulators on colorectal cancer: a prognostic role for insulin-like growth factor binding protein-5. | Clin Sci (Lond) | 2026 | 42047268 | PubTator, text mining | PubMed |
| Insulin-like growth factor-binding protein 5 promotes prostate cancer metastasis and osteoblastic activity by inducing chemokines and activating NF-κB signaling. | Cancer Cell Int | 2026 | 42035059 | PubTator, text mining | PubMed |
| PAPPA2 c.392G>C Heterozygous Mutation Associates Primary Open-Angle Glaucoma in a Chinese Family. | Hum Mutat | 2026 | 41993134 | PubTator, text mining | PubMed |
| Research progress in heterogeneity of dental mesenchymal stem cells. | Int J Oral Sci | 2026 | 41932866 | PubTator, text mining | PubMed |
| The IGF-1 senescence switch: a biphasic model for SASP-driven aging and precision senomodulation. | Cytokine | 2026 | 41905220 | PubTator, text mining | PubMed |
| Urine-Based Approaches for Screening, Diagnosis, and Surveillance of Urothelial Carcinoma. | J Pers Med | 2026 | 41893002 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of PAPPA Gene Reveals Tumor-Specific Prognostic Effects. | Biology (Basel) | 2026 | 41892220 | PubTator, text mining | PubMed |
| Glycolytic reprogramming mediated by the ADAM12/IGF1 axis promotes ossification of the posterior longitudinal ligament. | Cell Death Discov | 2026 | 41881952 | PubTator, text mining | PubMed |
| Therapeutic strategy for cervical gastric-type adenocarcinoma by targeting CLU to relieve CLU-associated stress and sensitize chemotherapy. | Precis Clin Med | 2026 | 41878236 | PubTator, text mining | PubMed |
Isolation methods influence the biological properties of Wharton's Jelly-derived mesenchymal stem cells: A comparative study of yield, viability, proliferation, differentiation potential, and proteomic profiles. | PLoS One | 2026 | 41860834 | PubTator, text mining | PubMed |
| Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer. | NPJ Breast Cancer | 2026 | 41844688 | PubTator, text mining | PubMed |
| Mechanistic dissection of GRHL2 and PR transcriptional co-regulation in breast cells. | PLoS Genet | 2026 | 41843622 | PubTator, text mining | PubMed |
| IGFBP5 Restores Endometrial Receptivity and Rescues Implantation Failure in Polycystic Ovary Syndrome. | Adv Sci (Weinh) | 2026 | 41816941 | PubTator, text mining | PubMed |
| Removing array-specific batch effects in GWAS mega-analyses by applying a two-step imputation workflow. | Bioinform Adv | 2026 | 41808772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3488/papers?page=2